MPS Pharmaa Limited (BOM:531686)

India flag India · Delayed Price · Currency is INR
1.650
0.00 (0.00%)
At close: Mar 9, 2026
-55.28%
Market Cap 31.53M
Revenue (ttm) 204.00
Net Income (ttm) -9.40M
Shares Out 19.11M
EPS (ttm) -0.50
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 32,002
Average Volume 5,169
Open 1.730
Previous Close n/a
Day's Range 1.650 - 1.730
52-Week Range 1.570 - 3.510
Beta -0.04
RSI 27.71
Earnings Date May 29, 2026

About MPS Pharmaa

MPS Pharmaa Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. The company offers generic products, including antibacterials, antiallergics, antifungals, anthelminthics, antihypertensives, antimalarials, antituberculosis, corticosteroids, erectile dysfunction, gastrointestinal agents, sedatives, and others, as well as analgesic, antipyretic, and anti-inflammatory products. It also offers ethical products, such as Wibatol, Wibatol-O, Robial, Twosum, Majispa, Arfa Gel, Stibomin, and Chewfe-... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 18
Stock Exchange Bombay Stock Exchange
Ticker Symbol 531686
Full Company Profile

Financial Performance

In fiscal year 2025, MPS Pharmaa's revenue was 477,204, a decrease of -49.05% compared to the previous year's 936,669. Losses were -8.98 million, 8.05% more than in 2024.

Financial Statements

News

There is no news available yet.